Cargando…
A Novel Quantification System Combining iTRAQ Technology and Multi-Omics Assessment to Predict Prognosis and Immunotherapy Efficacy in Colon Cancer
Background: Colon cancer is one of the most common cancer types, although it has certain unique genetic features. This study aimed to develop a unique score for assessing prognosis and immunotherapy efficacy using integrated multi-omics analysis. Methods: Isobaric tagging for relative and absolute q...
Autores principales: | Xia, Tianyi, Guo, Junnan, Zhang, Bomiao, Xue, Weinan, Deng, Shenhui, Liu, Yanlong, Cui, Binbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014007/ https://www.ncbi.nlm.nih.gov/pubmed/35445008 http://dx.doi.org/10.3389/fbioe.2022.862619 |
Ejemplares similares
-
Precise protein quantification based on peptide quantification using iTRAQ™
por: Boehm, Andreas M, et al.
Publicado: (2007) -
Editorial: Multi-Omics Technologies for Optimizing Synthetic Biomanufacturing
por: Kim, Young-Mo, et al.
Publicado: (2021) -
Differential urinary proteomics analysis of myocardial infarction using iTRAQ quantification
por: Zou, Lili, et al.
Publicado: (2019) -
Bisphenol A Promotes the Progression of Colon Cancer Through Dual-Targeting of NADPH Oxidase and Mitochondrial Electron-Transport Chain to Produce ROS and Activating HIF-1α/VEGF/PI3K/AKT Axis
por: Xia, Tianyi, et al.
Publicado: (2022) -
Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification
por: Ren, Tong, et al.
Publicado: (2016)